Atin Lamsal

676 total citations
12 papers, 295 citations indexed

About

Atin Lamsal is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Atin Lamsal has authored 12 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 1 paper in Organic Chemistry. Recurrent topics in Atin Lamsal's work include Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Atin Lamsal is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Atin Lamsal collaborates with scholars based in United States. Atin Lamsal's co-authors include Colleen M. Niswender, Michael R. Wood, P. Jeffrey Conn, Craig W. Lindsley, Thomas M. Bridges, J. Scott Daniels, Carrie K. Jones, Meredith J. Noetzel, Thomas J. Utley and Bruce J. Melancon and has published in prestigious journals such as Journal of Medicinal Chemistry, Neuropsychopharmacology and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Atin Lamsal

12 papers receiving 294 citations

Peers

Countries citing papers authored by Atin Lamsal

Since Specialization

Citations

This map shows the geographic impact of Atin Lamsal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atin Lamsal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atin Lamsal more than expected).

Fields of papers citing papers by Atin Lamsal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atin Lamsal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atin Lamsal. The network helps show where Atin Lamsal may publish in the future.

Co-authorship network of co-authors of Atin Lamsal

This figure shows the co-authorship network connecting the top 25 collaborators of Atin Lamsal. A scholar is included among the top collaborators of Atin Lamsal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atin Lamsal. Atin Lamsal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides 2017 ·Bioorganic & Medicinal Chemistry Letters ·James C. Tarr, Michael R. Wood, Meredith J. Noetzel, (unknown), Rebecca L. Weiner, Alice L. Rodriguez, Atin Lamsal, Frank W. Byers, Sichen Chang, Hyekyung P. Cho, Carrie K. Jones, Colleen M. Niswender, Michael W. Wood, Nicholas J. Brandon, Mark E. Duggan, P. Jeffrey Conn, Thomas M. Bridges, Craig W. Lindsley	16
2	Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides 2017 ·Bioorganic & Medicinal Chemistry Letters ·James C. Tarr, Michael R. Wood, Meredith J. Noetzel, Bruce J. Melancon, Atin Lamsal, Vincent B. Luscombe, Alice L. Rodriguez, Frank W. Byers, Sichen Chang, Hyekyung P. Cho, Darren W. Engers, Carrie K. Jones, Colleen M. Niswender, Michael W. Wood, Nicholas J. Brandon, Mark E. Duggan, P. Jeffrey Conn, Thomas M. Bridges, Craig W. Lindsley	11
3	Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition 2016 ·Bioorganic & Medicinal Chemistry Letters ·Michael R. Wood, Meredith J. Noetzel, James C. Tarr, Alice L. Rodriguez, Atin Lamsal, Sichen Chang, (unknown), Emery Smith, Peter Chase, Peter Hodder, Darren W. Engers, Colleen M. Niswender, Nicholas J. Brandon, Michael W. Wood, Mark E. Duggan, P. Jeffrey Conn, Thomas M. Bridges, Craig W. Lindsley	7
4	Challenges in the development of an M4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs 2016 ·Bioorganic & Medicinal Chemistry Letters ·Michael R. Wood, Meredith J. Noetzel, Michael S. Poslusney, Bruce J. Melancon, James C. Tarr, Atin Lamsal, Sichen Chang, Vincent B. Luscombe, Rebecca L. Weiner, Hyekyung P. Cho, Michael Bubser, Carrie K. Jones, Colleen M. Niswender, Michael W. Wood, Darren W. Engers, Nicholas J. Brandon, Mark E. Duggan, P. Jeffrey Conn, Thomas M. Bridges, Craig W. Lindsley	25
5	Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4) 2015 ·SLAS DISCOVERY ·Emery Smith, Peter Chase, Colleen M. Niswender, Thomas J. Utley, Douglas J. Sheffler, Meredith J. Noetzel, Atin Lamsal, Michael R. Wood, P. Jeffrey Conn, Craig W. Lindsley, Franck Madoux, (unknown), Louis Scampavia, Timothy Spicer, Peter Hodder	25
6	Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model 2015 ·Neuropsychopharmacology ·Ayan Ghoshal, Jerri M. Rook, Jonathan W. Dickerson, (unknown), Ryan D. Morrison, Nidhi Jalan‐Sakrikar, Atin Lamsal, Meredith J. Noetzel, Michael S. Poslusney, Michael R. Wood, Bruce J. Melancon, Shaun R. Stauffer, Zixiu Xiang, J. Scott Daniels, Colleen M. Niswender, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn	81
7	Development of a Highly Potent, Novel M₅Positive Allosteric Modulator (PAM) Demonstrating CNS Exposure: 1-((1H-Indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380) 2014 ·Journal of Medicinal Chemistry ·Patrick R. Gentry, Masaya Kokubo, Thomas M. Bridges, Meredith J. Noetzel, Hyekyung P. Cho, Atin Lamsal, Emery Smith, Peter Chase, Peter Hodder, Colleen M. Niswender, J. Scott Daniels, P. Jeffrey Conn, Craig W. Lindsley, Michael R. Wood	22
8	Discovery of ML326: The first sub-micromolar, selective M5 PAM 2013 ·Bioorganic & Medicinal Chemistry Letters ·Patrick R. Gentry, Thomas M. Bridges, Atin Lamsal, Paige N. Vinson, Emery Smith, Peter Chase, Peter Hodder, Julie L. Engers, Colleen M. Niswender, J. Scott Daniels, P. Jeffrey Conn, Michael R. Wood, Craig W. Lindsley	20
9	Development and characterization of a highly selective M5 PAM probe molecule with improved potency 2013 ·Patrick R. Gentry, Thomas M. Bridges, J. Scott Daniels, Atin Lamsal, Paige N. Vinson, Colleen M. Niswender, Peter Hodder, Hugh Rosen, P. Jeffrey Conn, Julie L. Engers, Craig W. Lindsley, Michael R. Wood	1
10	Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: Development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Bruce J. Melancon, Thomas M. Bridges, Paige N. Vinson, Thomas J. Utley, Atin Lamsal, Alice L. Rodriguez, Daryl F. Venable, Douglas J. Sheffler, Carrie K. Jones, Anna L. Blobaum, Michael R. Wood, J. Scott Daniels, P. Jeffrey Conn, Colleen M. Niswender, Craig W. Lindsley, Corey R. Hopkins	31
11	Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor 2012 ·Bioorganic & Medicinal Chemistry Letters ·James M. Salovich, Paige N. Vinson, Douglas J. Sheffler, Atin Lamsal, Thomas J. Utley, Anna L. Blobaum, Thomas M. Bridges, (unknown), Carrie K. Jones, Michael R. Wood, J. Scott Daniels, P. Jeffrey Conn, Colleen M. Niswender, Craig W. Lindsley, Corey R. Hopkins	28
12	Chemical Modification of the M₁Agonist VU0364572 Reveals Molecular Switches in Pharmacology and a Bitopic Binding Mode 2012 ·ACS Chemical Neuroscience ·Gregory J. Digby, Thomas J. Utley, Atin Lamsal, (unknown), Douglas J. Sheffler, Evan P. Lebois, Thomas M. Bridges, Michael R. Wood, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact